Clinical Trials Directory

Trials / Completed

CompletedNCT04123041

Characterize the Nicotine Uptake and Subjective Effects With Use of JUUL Electronic Nicotine Delivery Systems

A Randomized, Open-Label, Cross-Over Study to Characterize the Nicotine Uptake and Subjective Effects With Use of JUUL Electronic Nicotine Delivery Systems With Multiple Flavors and Nicotine Concentrations, Usual Brand of Combustible Cigarettes, a Comparator E-Cigarette and Nicotine Gum in Adult Smokers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
137 (actual)
Sponsor
Juul Labs, Inc. · Industry
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to estimate nicotine uptake and assess subjective effects during ad libitum use sessions of 4 flavors of JUUL ENDS (also referred to as nicotine salt pod system; NSPS) products (i.e., Virginia Tobacco, Mint, Menthol and Mango) with 2 different nicotine concentrations. Subjective effects will also be assessed to gain an understanding of the user's experience during and after JUUL ENDS product use to evaluate the abuse liability of the products. The subject population will consist of healthy adult, male and female smokers, 21 to 65 years of age.

Conditions

Interventions

TypeNameDescription
OTHERJUUL ENDS, Combustible cigarette, comparator e-cigarette, Nicorette gumJUUL ENDS and comparator e-cigarette will be used for 5 minutes ad libitum, one combustible cigarette will be used ad libitum, Nicorette gum will be used for 30 minutes ad libitum

Timeline

Start date
2019-09-23
Primary completion
2019-12-18
Completion
2019-12-18
First posted
2019-10-10
Last updated
2020-02-13

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04123041. Inclusion in this directory is not an endorsement.